Reiman, Eric M.
Translational Genomics Research Institute · University of Arizona · Banner Alzheimer’s Institute · Arizona Alzheimer’s Consortium
149 papers on CoChatORCID 0000-0002-0705-3696
Most cited papers
- Verified
Tracking Alzheimerʼs disease in transgenic mice using fluorodeoxyglucose autoradiography
Reiman, E. M., Uecker, A., Gonzalez-Lima, F., Minear, D., Chen, K., Callaway, N. L., Berndt, J. D., & Games, D. (2000) · NeuroReport
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 62
- Verified
Origin of the PSEN1 E280A mutation causing early‐onset Alzheimer's disease
Lalli, M. A., Cox, H. C., Arcila, M. L., Cadavid, L., Moreno, S., Garcia, G., Madrigal, L., Reiman, E. M., Arcos‐Burgos, M., Bedoya, G., et al. (2014) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsForensic and Genetic Research
Cited by 60
- Verified
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A., Bocanegra, Y., Aguillon, D., Guzmán-Vélez, E., Pardilla-Delgado, E., Ramirez-Gomez, L., et al. (2021) · Alzheimer's Research & Therapy
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 58
- Verified
Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred
Fuller, J. T., Cronin-Golomb, A., Gatchel, J. R., Norton, D. J., Guzmán-Vélez, E., Jacobs, H. I. L., Hanseeuw, B., Pardilla-Delgado, E., Artola, A., Baena, A., et al. (2019) · The Journal of Prevention of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 57
- Verified
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Neitzel, J., Franzmeier, N., Rubinski, A., Dichgans, M., Brendel, M., (ADNI), A. D. N. I., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., et al. (2021) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 57
- Verified
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
Su, Y., Blazey, T. M., Owen, C. J., Christensen, J. J., Friedrichsen, K., Joseph-Mathurin, N., Wang, Q., Hornbeck, R. C., Ances, B. M., Snyder, A. Z., et al. (2016) · PLOS ONE
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 56
- Verified
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
Wolf, A. B., Valla, J., Bu, G., Kim, J., LaDu, M., Reiman, E. M., & Caselli, R. J. (2013) · Alzheimer's Research & Therapy
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 55
- Verified
Association of Pituitary Adenylate Cyclase–Activating Polypeptide With Cognitive Decline in Mild Cognitive Impairment Due to Alzheimer Disease
Han, P., Caselli, R. J., Baxter, L., Serrano, G., Yin, J., Beach, T. G., Reiman, E. M., & Shi, J. (2015) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 55
- Verified
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., et al. (2023) · The Lancet Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 55
- Verified
Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease
Aguillon, D., Langella, S., Chen, Y., Sanchez, J. S., Su, Y., Vila‐Castelar, C., Vasquez, D., Zetterberg, H., Hansson, O., Dage, J. L., et al. (2023) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 54
- Verified
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification
Hett, K., Ta, V.-T., Catheline, G., Tourdias, T., Manjón, J. V., Coupé, P., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., et al. (2019) · Scientific Reports
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 49
- Verified
Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci
Holton, P., Ryten, M., Nalls, M., Trabzuni, D., Weale, M. E., Hernandez, D., Crehan, H., Gibbs, J. R., Mayeux, R., Haines, J. L., et al. (2013) · Annals of Human Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 48
- Verified
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
Levin, J., Vöglein, J., Quiroz, Y. T., Bateman, R. J., Ghisays, V., Lopera, F., McDade, E., Reiman, E., Tariot, P. N., & Morris, J. C. (2022) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 40
- Verified
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
Wisch, J. K., McKay, N. S., Boerwinkle, A. H., Kennedy, J., Flores, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., et al. (2024) · The Lancet Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 37
- Verified
Longitudinal white matter and cognitive development in pediatric carriers of the apolipoprotein ε4 allele
Remer, J., Dean, D. C., Chen, K., Reiman, R. A., Huentelman, M. J., Reiman, E. M., & Deoni, S. C. L. (2020) · NeuroImage
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 33
- Verified
Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease
Langella, S., Barksdale, N. G., Vasquez, D., Aguillon, D., Chen, Y., Su, Y., Acosta-Baena, N., Acosta-Uribe, J., Baena, A. Y., Garcia-Ospina, G., et al. (2023) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 30
- Verified
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study
Schworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T., Laymon, C. M., Tudorascu, D. L., Cohen, A. D., Zaman, S. H., Ances, B. M., et al. (2024) · The Lancet Neurology
Dementia and Cognitive Impairment ResearchDown syndrome and intellectual disability research
Cited by 29
- Verified
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits
Deming, Y., Xia, J., Cai, Y., Lord, J., Del-Aguila, J. L., Fernandez, M. V., Carrell, D., Black, K., Budde, J., Ma, S., et al. (2016) · Scientific Reports
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 28
- Verified
Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer’s prevention initiative registry
Torres, V. L., Vila-Castelar, C., Bocanegra, Y., Baena, A., Guzmán-Vélez, E., Aguirre-Acevedo, D. C., Tirado, V., Munoz, C., Henao, E., Moreno, S., et al. (2021) · Applied Neuropsychology: Adult
Dementia and Cognitive Impairment ResearchHistorical and Modern Theater Studies
Cited by 28
- Verified
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes
Riviere, M., Langbaum, J. B., Turner, R. S., Rinne, J. O., Sui, Y., Cazorla, P., Ricart, J., Meneses, K., Caputo, A., Tariot, P. N., et al. (2024) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 28
- Verified
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene
Aguirre-Acevedo, D. C., Jaimes-Barragán, F., Henao, E., Tirado, V., Muñoz, C., Reiman, E. M., Tariot, P. N., Langbaum, J. B., & Lopera, F. (2016) · International Psychogeriatrics
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 25
- Verified
Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment
Smith, G. S., Protas, H., Kuwabara, H., Savonenko, A., Nassery, N., Gould, N. F., Kraut, M., Avramopoulos, D., Holt, D., Dannals, R. F., et al. (2023) · NeuroImage: Clinical
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 22
- Verified
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s microglia
Haney, M. S., Pálovics, R., Munson, C. N., Long, C., Johansson, P., Yip, O., Dong, W., Rawat, E., West, E., Schlachetzki, J. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 20
- Verified
Amyloid-β predominant Alzheimer’s disease neuropathologic change
Kovacs, G. G., Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Forrest, S. L., Alzheimer's Disease Genetics Consortium, Bowen, J. D., Crane, P. K., Jarvik, G. P., et al. (2025) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free